Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Kalyan Roy: The Critical Role of Chelation Therapy in Thalassaemia
Kalyan Roy/ LinkedIn
May 28, 2026, 14:00

Kalyan Roy: The Critical Role of Chelation Therapy in Thalassaemia

Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:

“Iron Overload in Thalassaemia.

The silent threat of chronic transfusion therapy.

For patients with β-thalassaemia major, regular blood transfusion is lifesaving — but repeated transfusions gradually lead to iron overload (Transfusional Hemosiderosis).

Since the body cannot effectively remove excess iron, iron accumulates in vital organs over time.

Organs affected

Excess iron deposition commonly affects:

  • Heart
  • Liver
  • Endocrine glands
  • Pancreas

This may result in:

  • Cardiomyopathy
  • Arrhythmia
  • Liver fibrosis and cirrhosis
  • Diabetes mellitus
  • Delayed puberty and hormonal dysfunction

Monitoring iron overload

Early detection is essential.

  • Important investigations include:
  • Serum Ferritin
  • MRI T2 of Heart and Liver
  • Liver Iron Concentration (LIC)
  • Cardiac and Endocrine Evaluation

MRI T2 remains one of the most valuable non-invasive tools for assessing cardiac and hepatic iron burden.

Iron chelation therapy

Iron chelation is the cornerstone of management and significantly improves long-term survival.

Common Chelators:

  • Deferasirox (DFX)
  • Deferiprone (DFP)
  • Deferoxamine (DFO)

Treatment should always be individualized based on:

  • Iron burden
  • Organ involvement
  • Patient compliance
  • Clinical response

Long-term care is essential.

Successful thalassaemia management requires:

  • Regular iron monitoring
  • Timely chelation adjustment
  • Multidisciplinary follow-up
  • Cardiac, liver and endocrine surveillance

Modern thalassaemia care focuses not only on survival — but also on preserving long-term quality of life.

Final thought

Iron overload remains one of the most important complications in chronically transfused thalassaemia patients.

Early diagnosis, appropriate chelation therapy, and continuous monitoring can dramatically reduce organ damage and improve survival.

Better transfusion support must always include better iron management.”

Kalyan Roy: The Critical Role of Chelation Therapy in Thalassaemia

Stay updated with Hemostasis Today.

 

Chelation Therapy Deferasirox Deferiprone Deferoxamine Health Hematology Hemostasis Hemostasis News Hemostasis Today iron overload Kalyan Roy Medicine Thalassaemia
NewsFeed